Dipivefrin ophthalmic Pregnancy and Breastfeeding Warnings
Brand names: AK-Pro, Propine
Dipivefrin ophthalmic Pregnancy Warnings
Dipivefrin has been assigned to pregnancy category B by the FDA. Animal studies have revealed no evidence of fetal harm or teratogenicity. There are no controlled data in human pregnancy. Dipivefrin is only recommended for use during pregnancy when benefit outweighs risk.
Dipivefrin ophthalmic Breastfeeding Warnings
There are no data on the excretion of dipivefrin into human milk. The manufacturer recommends that caution be used when administering dipivefrin to nursing women.
See also
References for pregnancy information
- Product Information. Propine (dipivefrin ophthalmic). Allergan Inc. 2022.
References for breastfeeding information
- Product Information. Propine (dipivefrin ophthalmic). Allergan Inc. 2022.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
